SEC Form 4 · accession 0001209191-16-130295
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert F Apple
Officer — President & CEO · Director
Period of report
Jun 30, 2016
Accepted (ET)
Jun 30, 2016 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2016 | A | 11,223 | $1.05 | A | 869,719 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares awarded at the end of the performance period for performance stock units previously granted under the Antares Pharma, Inc. 2008 Equity Compensation Plan.